Hot Investor Mandate: New York-Based Family Office Seeking Early-Stage Therapeutic Investment Opportunities

20 Dec

A family office, based in New York City, is looking to invest in therapeutics. The firm is most interested in companies that are IND ready through raising funds for Phase IIb clinical trials. The firm is willing to lead or co-invest, and will invest between $100K-$1.5M, depending on the round and the financial needs of the company. Historically, the firm has focused on investing in US and Israel.

The firm is interested primarily in therapeutics technologies. While agnostic to type of therapeutic, and open to most indications, much of the firm’s previous investments have been in oncology, cardiovascular or CNS related indications. The firm will invest as early as IND-ready companies, but no later than companies raising money for Phase IIb trials.

The firm has no specific company or management team requirements.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: